NCT07169851 2026-03-06
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
Clinical Trials
107 trialsNCT07008027 2026-02-19
Real World Asparaginase Therapy Toxicity
St. Jude Children's Research Hospital
Not yet recruiting
NCT07238075 2026-02-17
ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers
Adcytherix SAS
Phase 1 Recruiting
NCT00400946 2026-02-13
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Dana-Farber Cancer Institute
Phase 3 Completed
NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT07354971 2026-01-21
IMMUNO-FIT Observational Study
University Hospital Southampton NHS Foundation Trust
Not yet recruiting
NCT05512169 2026-01-15
MPGx-INDALL
University of Geneva, Switzerland
Recruiting
NCT07319364 2026-01-06
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1 Recruiting
NCT06120712 2025-12-23
MIZAR-002
Shanghai Juncell Therapeutics
Phase 1/2 Completed
NCT05417750 2025-12-10
MIZAR-001
Shanghai Juncell Therapeutics
Phase 1 Completed
NCT07264985 2025-12-04
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
Not yet recruiting
NCT07237906 2025-11-20
Neutropenia With TNF-α Inhibitors
Istanbul University - Cerrahpasa
Completed
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06726590 2025-09-12
IPGx Registry
Texas A&M University
Recruiting
NCT07063706 2025-07-18
Pharmaceutical Care for Patients Using Capecitabine
Faculdade de Farmácia
Phase NA Completed
NCT06789601 2025-06-19
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Brigham and Women's Hospital
Phase 1/2 Recruiting
NCT06716619 2025-03-26
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting
NCT05096338 2025-03-18
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04659343 2025-03-05
TDM for Optimized Outcome in Patients With mRCC.
University of Aarhus
Recruiting
NCT05652673 2025-02-28
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Erasmus Medical Center
Phase NA Recruiting
NCT05355168 2024-12-31
Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma
Anhui Provincial Hospital
Phase 2 Completed
NCT06302062 2024-12-03
TAL-T
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1 Recruiting
NCT06407401 2024-11-05
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Not yet recruiting
NCT06558084 2024-08-16
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Completed
NCT04696081 2024-08-09
AFIB-CANCER
University Hospital, Caen
Recruiting
NCT06483685 2024-07-03
RADIANTS
University Hospital, Caen
Active not recruiting
NCT05838638 2024-05-16
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
University of Central Florida
Phase NA Recruiting
NCT05022797 2024-05-13
Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Terminated
NCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
NCT06291688 2024-03-04
Applying Mobile Healthcare Education to Improve Cutaneous Self-care Capability
National Taiwan University Hospital
Phase NA Unknown
NCT05717699 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT05717712 2024-02-28
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Capital Medical University
Phase 1 Recruiting
NCT03638375 2023-12-12
ACTME
Leiden University Medical Center
Phase 1/2 Unknown
NCT05137847 2023-12-12
A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
Eisai Inc.
Completed
NCT06152471 2023-11-30
ASF-BC
Uppsala University Hospital
Phase 3 Unknown
NCT00074165 2023-07-06
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
OHSU Knight Cancer Institute
Phase 2 Terminated
NCT00052884 2023-06-18
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Eastern Cooperative Oncology Group
Phase 1 Terminated
NCT03882580 2023-04-24
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
Unknown
NCT04279470 2023-04-13
CARTABLE
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT05800054 2023-04-05
Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase NA Recruiting
NCT04138381 2023-03-27
SeliGIST
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Unknown
NCT04770922 2023-02-16
Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia
Cipherome, Inc.
Completed
NCT00003407 2023-02-02
Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML
Rush University Medical Center
Phase 2 Withdrawn
NCT05266300 2022-11-01
Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.
University of Southern Denmark
Completed
NCT05472350 2022-07-25
Efficacy and Safety of Perioperative Use of Breztri Aerosphere to Relieve Cough After Lobectomy
The First Affiliated Hospital of Guangzhou Medical University
Phase NA Unknown
NCT05376943 2022-05-17
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Unknown
NCT04690231 2022-03-15
Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma
Peking University People's Hospital
Phase NA Completed
NCT04791150 2021-05-10
Rheumatologic Adverse Events and Cancer Immunotherapy
Poitiers University Hospital
Phase NA Unknown
NCT02864030 2021-03-04
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
Oncologia Medica dell'Ospedale Fatebenefratelli
Phase 4 Completed